Trends in Industrialization and Commercialization of IgY Technology

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2022 Nov 7

PMID 36341353

Authors

Saeed Yakhkeshi

Rao Wu

Brindha Chelliappan

Xiaoying Zhang

Affiliations

Soon will be listed here.

Abstract

IgY technology refers to the strategic production process involved in generating avian immunoglobulin (IgY) against target antigens in a much more cost-effective manner with broad applications in the fields of diagnostics, prophylaxis, and therapeutics for both human and veterinary medicine. Over the past decade, promising progress in this research area has been evident from the steep increase in the number of registered manufacturing companies involved in the production of IgY products, the number of patents, and the notable number of clinical trials underway. Hence, it is crucial to conduct a prospective analysis of the commercialization and marketing potential of IgY-based commercial products for large-scale applications. This review revealed that the number of IgY patent applications increased steeply after 2010, with the highest of 77 patents filed in 2021. In addition, 73 industries are reportedly involved in marketing IgY products, out of which 27 were promoting biotherapeutics for human and veterinary medicine and 46 were in the diagnostic field. IgY antibodies are being used as primary and secondary antibodies, with approximately 3729 and 846 products, respectively. Biotherapeutic product consumption has notably increased as a food supplement and as a topical application in human and veterinary medicine, which are under different clinical phases of development to reach the market with around 80 and 56 products, respectively. In contrast, the number of IgY products as parenteral administrations and licensed drugs is not well developed given the lack of technical standards established for IgY registration and industrialization, as well as the restriction of the nature of polyclonal antibodies. However, recent ongoing research on functional IgY fragments indicates a promising area for IgY applications in the near future. Therefore, retrospective analysis with speculations is mandatory for IgY technology maturation toward industrialization and commercialization.

Citing Articles

P23-Specific IgY Significantly Reduces Diarrhea and Oocyst Shedding in Calves Experimentally Infected with .

Mira A, Garro C, de Alba P, Monti D, Lang M, Vivas A Vaccines (Basel). 2025; 13(2).

PMID: 40006709 PMC: 11860195. DOI: 10.3390/vaccines13020162.

A novel and quick egg yolk immunoglobulin y antibody extraction method leveraging the protein liquid-liquid phase separation principle.

Isah M, Yuzhang H, Dang M, Zhang X Poult Sci. 2025; 104(2):104804.

PMID: 39813868 PMC: 11782816. DOI: 10.1016/j.psj.2025.104804.

Comparison of immunoglobulin Y antibody production in new and spent laying hens.

Metheenukul P, Surachetpong W, Prasertsincharoen N, Arreesrisom P, Thengchaisri N Vet World. 2024; 17(9):2177-2184.

PMID: 39507799 PMC: 11536739. DOI: 10.14202/vetworld.2024.2177-2184.

A novel antibody treatment reduces deformed wing virus loads in the western honey bee ().

MacMillan N, Hause B, Nordseth T, Felden A, Baty J, Pitman J mSphere. 2024; 9(11):e0049724.

PMID: 39475320 PMC: 11580425. DOI: 10.1128/msphere.00497-24.

Long-Term Oral Administration of Hyperimmune Egg-Based IgY-Rich Formulations Induces Mucosal Immune Response and Systemic Increases of Cytokines Involved in Th2- and Th17-Type Immune Responses in C57BL/6 Mice.

Nastasa V, Minea B, Pasca A, Bostanaru-Iliescu A, Stefan A, Gologan D Int J Mol Sci. 2024; 25(16).

PMID: 39201385 PMC: 11354499. DOI: 10.3390/ijms25168701.

References

Schade R, Calzado E, Sarmiento R, Chacana P, Porankiewicz-Asplund J, Terzolo H . Chicken egg yolk antibodies (IgY-technology): a review of progress in production and use in research and human and veterinary medicine. Altern Lab Anim. 2005; 33(2):129-54. DOI: 10.1177/026119290503300208. View

Frumkin L, Lucas M, Scribner C, Ortega-Heinly N, Rogers J, Yin G . Egg-Derived Anti-SARS-CoV-2 Immunoglobulin Y (IgY) With Broad Variant Activity as Intranasal Prophylaxis Against COVID-19. Front Immunol. 2022; 13:899617. PMC: 9199392. DOI: 10.3389/fimmu.2022.899617. View

Yokoyama H, Peralta R, Sendo S, Ikemori Y, Kodama Y . Detection of passage and absorption of chicken egg yolk immunoglobulins in the gastrointestinal tract of pigs by use of enzyme-linked immunosorbent assay and fluorescent antibody testing. Am J Vet Res. 1993; 54(6):867-72. View

Ge S, Xu L, Li B, Zhong F, Liu X, Zhang X . Canine Parvovirus is diagnosed and neutralized by chicken IgY-scFv generated against the virus capsid protein. Vet Res. 2020; 51(1):110. PMC: 7468180. DOI: 10.1186/s13567-020-00832-7. View

Zhang X, Calvert R, Sutton B, Dore K . IgY: a key isotype in antibody evolution. Biol Rev Camb Philos Soc. 2017; 92(4):2144-2156. DOI: 10.1111/brv.12325. View

Li C, He J, Ren H, Zhang X, Du E, Li X . Preparation of a Chicken scFv to Analyze Gentamicin Residue in Animal Derived Food Products. Anal Chem. 2016; 88(7):4092-8. DOI: 10.1021/acs.analchem.6b00426. View

Tsurushita N, Park M, Pakabunto K, Ong K, Avdalovic A, Fu H . Humanization of a chicken anti-IL-12 monoclonal antibody. J Immunol Methods. 2005; 295(1-2):9-19. DOI: 10.1016/j.jim.2004.08.018. View

Tian Z, Zhang X . Progress on research of chicken IgY antibody-FcRY receptor combination and transfer. J Recept Signal Transduct Res. 2012; 32(5):231-7. DOI: 10.3109/10799893.2012.703207. View

Ortega-Vinuesa J, Bastos-Gonzalez D, Hidalgo-Alvarez R . A comparative study between the adsorption of IgY and IgG on latex particles. J Biomater Sci Polym Ed. 2000; 11(6):657-73. DOI: 10.1163/156856200743931. View

10.

Lee L, Samardzic K, Wallach M, Frumkin L, Mochly-Rosen D . Immunoglobulin Y for Potential Diagnostic and Therapeutic Applications in Infectious Diseases. Front Immunol. 2021; 12:696003. PMC: 8220206. DOI: 10.3389/fimmu.2021.696003. View

11.

Wu R, Yakhkeshi S, Zhang X . Scientometric analysis and perspective of IgY technology study. Poult Sci. 2022; 101(4):101713. PMC: 8844298. DOI: 10.1016/j.psj.2022.101713. View

12.

Gujral N, Lobenberg R, Suresh M, Sunwoo H . In-vitro and in-vivo binding activity of chicken egg yolk immunoglobulin Y (IgY) against gliadin in food matrix. J Agric Food Chem. 2012; 60(12):3166-72. DOI: 10.1021/jf205319s. View

13.

Rader C, Steinberger P, Fuller R, Barbas 3rd C . Methods for the generation of chicken monoclonal antibody fragments by phage display. J Immunol Methods. 2000; 242(1-2):159-81. DOI: 10.1016/s0022-1759(00)00221-0. View

14.

Lee W, Syed Atif A, Tan S, Leow C . Insights into the chicken IgY with emphasis on the generation and applications of chicken recombinant monoclonal antibodies. J Immunol Methods. 2017; 447:71-85. DOI: 10.1016/j.jim.2017.05.001. View

15.

da Silva W, Tambourgi D . IgY: a promising antibody for use in immunodiagnostic and in immunotherapy. Vet Immunol Immunopathol. 2010; 135(3-4):173-80. PMC: 7126787. DOI: 10.1016/j.vetimm.2009.12.011. View

16.

Ge S, Wu R, Zhou T, Liu X, Zhu J, Zhang X . Specific anti-SARS-CoV-2 S1 IgY-scFv is a promising tool for recognition of the virus. AMB Express. 2022; 12(1):18. PMC: 8840941. DOI: 10.1186/s13568-022-01355-4. View

17.

ODonnell K, Meberg B, Schiltz J, Nilles M, Bradley D . Zika Virus-Specific IgY Results Are Therapeutic Following a Lethal Zika Virus Challenge without Inducing Antibody-Dependent Enhancement. Viruses. 2019; 11(3). PMC: 6466411. DOI: 10.3390/v11030301. View

18.

Rahman S, Nguyen S, Icatlo Jr F, Umeda K, Kodama Y . Oral passive IgY-based immunotherapeutics: a novel solution for prevention and treatment of alimentary tract diseases. Hum Vaccin Immunother. 2013; 9(5):1039-48. PMC: 3899138. DOI: 10.4161/hv.23383. View

19.

Abdiche Y, Harriman R, Deng X, Yeung Y, Miles A, Morishige W . Assessing kinetic and epitopic diversity across orthogonal monoclonal antibody generation platforms. MAbs. 2015; 8(2):264-77. PMC: 4966639. DOI: 10.1080/19420862.2015.1118596. View

20.

Nishibori N, Horiuchi H, Furusawa S, Matsuda H . Humanization of chicken monoclonal antibody using phage-display system. Mol Immunol. 2005; 43(6):634-42. DOI: 10.1016/j.molimm.2005.04.002. View